← Open Payments lookup

BRITTANY FEVRIER: Open Payments

NPI 1598919219 · RIVERSIDE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,495 in 58 payments from 16 companies in 2025. Trend: 2023 $773 · 2024 $1,352 · 2025 $1,495

Food & beverage: $1,495
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$256
Alexion Pharmaceuticals, Inc.6$239
Novo Nordisk Inc5$144
Bayer Healthcare Pharmaceuticals Inc.6$141
Aurinia Pharma U.S., Inc.6$123
Fresenius USA Marketing, Inc.6$107
Travere Therapeutics, Inc.3$80
Boehringer Ingelheim Pharmaceuticals, Inc.4$75
Calliditas Therapeutics US Inc.2$62
Vifor Pharma, Inc.3$54

Products named: ULTOMIRIS, Ozempic, Kerendia, LOKELMA, LUPKYNIS, VELPHORO, JARDIANCE, TARPEYO.

Industry payments across RI — which companies pay providers there.